Biogen Idec Demonstrates Commitment to Advancing Hemophilia Research and Care at Annual ASH Meeting
Biogen Idec will present new data from its hemophilia clinical development and research programmes at the 55th Annual Meeting of the American Society of Hematology (ASH), taking place in New Orleans, 7–10 December.
Reflecting Biogen Idec’s commitment to transform hemophilia care, researchers will discuss 10 abstracts covering the breadth of the company’s comprehensive basic and clinical research programmes. This includes new, interim data from Phase III studies in pediatric populations evaluating the company’s investigational long-lasting recombinant factor VIII Fc fusion protein candidate, ELOCTATE, for hemophilia A and factor IX Fc fusion protein candidate, ALPROLIX, for hemophilia B.
“These new data from our groundbreaking research and development programmes demonstrate our commitment to improving hemophilia treatment,” said Glenn Pierce, MD, PhD, senior vice president of Global Medical Affairs and chief medical officer at Biogen Idec’s hemophilia therapeutic area. “We are excited to share our findings with physicians on the front lines of hemophilia management to further the understanding of the disorder.”
The titles of key Biogen Idec presentations are as follows:
ELOCTATE
• Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Pediatric Subjects with Hemophilia A: An Interim Analysis of the Kids A-LONG Study, Poster #3609 — Monday 9 December — 6:00–8:00 PM (CST)
• Dosing Long-Lasting Recombinant Factor VIII Fc Fusion Protein: Experience in the A-LONG Study, Poster #3598 — Monday 9 December — 6:00–8:00 PM (CST)
• The Bleeding Tendency In Relation To Predicted FVIII Activity Levels In Severe Hemophilia A Patients Treated With Recombinant Factor VIII Fc Fusion Protein, Poster #3590 — Monday 9 December — 6:00–8:00 PM (CST)
ALPROLIX
• Association of Bleeding Tendency with Time Under Target FIX Activity Levels in Severe Hemophilia B Patients Treated with Recombinant Factor IX Fc Fusion Protein, Poster #2349 — Sunday 8 December — 6:30–8:30 PM (CST)
• Pharmacokinetics, Safety and Efficacy of Long-lasting Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Adolescent Subjects with Hemophilia B: A Subgroup Analysis of the B-LONG Study, Poster #2350 — Sunday 8 December — 6:30–8:30 PM (CST)
• Pharmacokinetics of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Pediatric Subjects with Hemophilia B: An Interim Analysis of the Kids B-LONG Study, Poster #3599 — Monday 9 December — 6:00–8:00 PM (CST)
Hemophilia Health Outcomes Research
• Psychometric Evaluation of Health-Related Quality of Life Data from the A-LONG and B-LONG Hemophilia Clinical Trials, Oral Presentation/Abstract #423 — Monday 9 December — 11:00 AM (CST)
Nonclinical Research
• Evidence for Flexible Tethering of Fc to FVIII in Recombinant FVIII-Fc Fusion Protein rFVIIIFc, Poster #1102 — Saturday 7 December — 5:30–7:30 PM (CST)
• Immunohistochemical Staining of rFVIIIFc and rFVIII in Liver Cells Differentiates between a VWF-Dependent and Independent Clearance Pathway in Mice, Poster #2331 — Sunday 8 December — 6:30–8:30 PM (CST)
• An Immunodeficient Mice Model with Circulating Human Platelets to Evaluate the Platelet Clearance and Pharmacokinetics of Platelet-targeted Coagulator Factor VIIa, Abstract #2345 — Sunday 8 December — 6:30–8:30 PM (CST)
Full session details and data abstracts for the 2013 Annual Meeting can be found on the ASH website. Full-text abstracts will be published in the 6 December issue of Blood, the journal of ASH.
Regulatory applications for ELOCTATE and ALPROLIX are currently under review in several countries including the US, Canada and Australia.
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance